Acurx Pharmaceuticals's total assets for Q1 2025 were $4.80M, an increase of 24.55% from the previous quarter. ACXP total liabilities were $2.49M for the fiscal quarter, a -23.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.